Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

Authors

Usama Gergis MD, MBA, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

12-2017

Volume

130

Issue

1

Published In/Presented At

https://doi.org/10.1182/blood.V130.Suppl_1.2627.2627

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article